Loading clinical trials...
Loading clinical trials...
Epidemiology in Humans of New Arbovirusus Sorted Out From Metagenomic Screen in Local Vectors and Animal Hosts.
A local network is being set up to study the impact of arboviruses in our region. It is committed to a one-health approach, in particular with research without a priori for new viruses hosted among vectors and wildlife. The candidates identified by high throughput sequencing approaches will serve as a basis for the development of serological and molecular tools for their detections. These tools will be used to assess the possible circulation of these new viruses in humans in biological collections created within the framework of this project Arbodocc .
Age
0 - 80 years
Sex
ALL
Healthy Volunteers
Yes
Uh Montpellier
Montpellier, France
Start Date
January 1, 2020
Primary Completion Date
December 20, 2024
Completion Date
December 30, 2024
Last Updated
July 8, 2021
400
ESTIMATED participants
Lead Sponsor
University Hospital, Montpellier
Collaborators
NCT07291206
NCT04619823
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT04725110